申请人:Novartis AG
公开号:US10124065B2
公开(公告)日:2018-11-13
This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1-R4, L and X are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
本发明提供了一种式(I)化合物:或其药学上可接受的盐,其中 R1-R4、L 和 X 在此定义。式(I)化合物及其药学上可接受的盐是一种阳离子脂质,可用于向细胞和组织递送生物活性剂。